In
2007, a team of doctors in Berlin, Germany, including Gero Hütter,
performed a stem cell transplant for leukemia patient Timothy Ray Brown,
who was also HIV-positive. From 60 matching donors, they selected a
[CCR5]-Δ32 homozygous individual with two genetic copies of a rare
variant of a cell surface receptor. This genetic trait confers
resistance to HIV infection by blocking attachment of HIV to the cell.
Roughly one in 1000 people of European ancestry have this inherited
mutation, but it is rarer in other populations. The transplant was
repeated a year later after a relapse. Over three years after the
initial transplant and despite discontinuing antiretroviral therapy,
researchers cannot detect HIV in the transplant recipient's blood or in
various biopsies.. Levels of HIV-specific antibodies have also declined,
leading to speculation that the patient may have been functionally
cured of HIV. However, scientists emphasise that this is an unusual
case. Potentially fatal transplant complications (the "Berlin patient"
suffered from graft-versus-host disease and leukoencephalopathy) mean
that the procedure could not be performed in others with HIV, even if
sufficient numbers of suitable donors were found.
No comments:
Post a Comment